No adverse events were observed in clozapine‐treated patients on extended hematologic monitoring intervals during the coronavirus pandemic in four psychiatric centers in Japan

AIM: As an emergency measure during the coronavirus disease pandemic, the monitoring interval for clozapine use was temporarily extended beyond the regulatory requirement in Japan, which is the safest monitoring interval worldwide. In this study, we aimed to explore the effect of this measure on pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hata, Masahiro, Fujimoto, Michiko, Kanai, Koji, Yoshiyama, Kenji, Nakatani, Yoshitaka, Nakabayashi, Daiji, Maemura, Saki, Kawata, Shinya, Hakozaki, Takaaki, Nishikura, Shuya, Umemoto, Aiko, Sasada, Toru, Iwata, Kazuhiko, Tanaka, Hideki, Mamoto, Akiko, Toi, Yuuki, Taniguchi, Norio, Saito, Makiko, Kimura, Yoshio, Kishimoto, Kazuko, Hayami, Megumi, Ikeda, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013689/
https://www.ncbi.nlm.nih.gov/pubmed/33606356
http://dx.doi.org/10.1002/npr2.12166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013689/
https://www.ncbi.nlm.nih.gov/pubmed/33606356
http://dx.doi.org/10.1002/npr2.12166

Ejemplares similares